BPI-42

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameBPI-42

Drug Alias NameXMP-200

ClassificationBiologics

Mechanisms of ActionCell membrane permeability enhancers

TargetsUpdating

Therapy Area/IndicationsEye Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesXoma Corp

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesXoma Corp

Active IndicationsN/A

Inactive IndicationsEye Diseases

ATC CodeN/A